Coreg and Ventricular hypertrophy - a phase IV clinical study of FDA data

Summary:

Ventricular hypertrophy is reported as a side effect among people who take Coreg (carvedilol), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Lasix, and have Pain.

The phase IV clinical study analyzes which people have Ventricular hypertrophy when taking Coreg. It is created by eHealthMe based on reports of 48,155 people who have side effects when taking Coreg from the FDA, and is updated regularly.

What is Coreg?

Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,583 Coreg users. Check the latest studies of Coreg.

What is Ventricular hypertrophy?

Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart) is found to be associated with 695 drugs and 794 conditions by eHealthMe. Check the latest studies of Ventricular hypertrophy.

On Aug, 07, 2026

48,155 people reported to have side effects when taking Coreg.
Among them, 64 people (0.13%) have Ventricular hypertrophy.

Could Coreg cause Ventricular hypertrophy?

Among these 64 people:

How long have people been on Coreg when they have Ventricular hypertrophy? *

What is the gender of people who have Ventricular hypertrophy when taking Coreg? *

female: 43.33 %
male: 56.67 %

What is the age of people who have Ventricular hypertrophy when taking Coreg? *

What are other drugs people take besides Coreg? *

What are other side effects people have besides Ventricular hypertrophy? *

Cardiac Failure Congestive: 33 people, 51.56%
Chest Pain: 30 people, 46.88%
Mitral Valve Incompetence (inefficient heart valve): 29 people, 45.31%
Dyspnea (difficult or laboured breathing): 24 people, 37.50%
Heart Attack: 22 people, 34.38%
Anaemia (lack of blood): 21 people, 32.81%
Tricuspid Valve Incompetence (inefficient heart valve): 21 people, 32.81%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 19 people, 29.69%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 18 people, 28.12%
Ejection Fraction Decreased (systolic heart failure): 17 people, 26.56%

What are the existing conditions these people have? *

Pain: 15 people, 23.44%
Multiple Myeloma (cancer of the plasma cells): 6 people, 9.38%
High Blood Cholesterol: 6 people, 9.38%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 7.81%
Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 7.81%
Cardiac Disorder: 4 people, 6.25%
Sleep Disorder: 4 people, 6.25%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 3 people, 4.69%
Allergic Rhinitis: 3 people, 4.69%
Gastric Ulcer (stomach ulcer): 3 people, 4.69%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg and have Ventricular hypertrophy?

- Check whether Ventricular hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Coreg:

Coreg (49,583 reports)

Browse all side effects of Coreg:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular hypertrophy:

Ventricular hypertrophy (695 drugs)

Browse all the conditions that are associated with Ventricular hypertrophy:

Ventricular hypertrophy (794 conditions)

Related publications that referenced our studies

Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on carvedilol (the active ingredients of Coreg) and Coreg (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.